Metabolism: Muscle signals to the rescue
When indulging in a tasty meal, we rarely consider the amount of communication that takes place between various organs in our bodies. A multitude of signals flow between the digestive system and the brain, which regulate our appetite and help the body to metabolize foods by extracting nutrients and converting them into energy. However, much remains unknown about the molecular signaling pathways that regulate this internal conversation.
Fruit flies use many of the same mechanisms as humans to regulate food intake and balance energy levels, and are therefore a popular model for studying metabolism and metabolic diseases (Doane, 1960; Baker and Thummel, 2007; Musselman and Kühnlein, 2018). By manipulating the activity of individual genes in specific tissues, researchers have been able to gain more insight into how organs communicate on a molecular level. For example, it emerged that skeletal muscle – as opposed to cardiac and smooth muscle – is the source of a variety of metabolic signals that induce changes in other tissues, some of which have been found to affect the storage of fat (Benatti and Pedersen, 2014; Fisher and Maratos-Flier, 2015; Eckel, 2019). Now, in eLife, Arpan Ghosh, Norbert Perrimon and colleagues – who are based at Harvard Medical School and the Harvard Chan Bioinformatics Core – report that a signaling molecule released by skeletal muscle can protect flies from becoming obese (Ghosh et al., 2020).
The researchers studied a molecule called Pvf, which is the equivalent of two signaling factors that regulate cell growth and division in humans, called PDGF and VEGF. Fruit flies have multiple versions of the Pvf protein, which Ghosh et al. deactivated in various tissues. The experiments revealed that one of these subtypes, called Pvf1, protects adult flies against obesity by preventing excess fat from accumulating in storage sites (the fly adipose tissue) and in specialized cells called oenocytes. Oenocytes help the body absorb and break down fats to provide additional energy to cells in times of stress (Makki et al., 2014).
Ghosh et al. found that oenocytes contained high numbers of PvR, the receptor for Pvf1. When the receptor in these cells was deactivated, the flies stored more fat, similar to what was observed when the production of Pvf1 was turned off in the skeletal muscle. This suggests that communication between the muscle and oenocytes via Pvf1 and its receptor PvR is required to regulate the fat metabolism in the adult fly.
Further experiments showed that blocking a specific signaling pathway (called PI3K/Akt1/TOR) in oenocytes also led to an accumulation of fats, while reactivating the pathway prevented it. Moreover, when Pvf1 was turned off in the skeletal muscle, the signaling pathway in the oenocytes was also impaired. To better understand the role of this pathway in fat mobilization and synthesis, the researchers measured the rates of fat release from stores and new fat synthesis. Blocking this pathway had no effect on mobilizing fat from fat stores. Instead, fat synthesis increased, although the underlying mechanisms remain unclear.
To find out if this communication pathway is more important at a specific point in a fly’s life, Ghosh et al. turned their attention to young adult flies. During this age, the animals rapidly accumulate fat before achieving the steady, balanced level characteristic of mature adults. Indeed, the production of Pvf1 in the adult muscle peaked around the time when adult fat stores in the adipose tissue reached a steady-state capacity. However, when the flies were genetically modified to produce Pvf1 in the muscle earlier than normal and at higher levels, the young adults failed to store as much fat. This suggests that Pvf1 needs to be produced at a specific time and quantity to help young adult flies accumulate the right amount of fat.
Taken together, these findings show that Pvf1 released from skeletal muscle helps to end the normal increase of fat stores in young adult flies. This slows down the production of new fat, thus preventing obesity in mature adults. These results provide new insights into how internal organs communicate with each other to maintain energy levels. Further studies are needed to better understand how this muscle-derived signaling cascade regulates fat accumulation in vertebrates.
References
-
Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulationNature Reviews Rheumatology 11:86–97.https://doi.org/10.1038/nrrheum.2014.193
-
Myokines in metabolic homeostasis and diabetesDiabetologia 62:1523–1528.https://doi.org/10.1007/s00125-019-4927-9
-
Understanding the physiology of FGF21Annual Review of Physiology 78:223–241.https://doi.org/10.1146/annurev-physiol-021115-105339
-
The development and functions of oenocytesAnnual Review of Entomology 59:405–425.https://doi.org/10.1146/annurev-ento-011613-162056
-
Drosophila as a model to study obesity and metabolic diseaseThe Journal of Experimental Biology 221:jeb163881.https://doi.org/10.1242/jeb.163881
Article and author information
Author details
Publication history
Copyright
© 2020, Diaz and Reis
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,374
- views
-
- 82
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Epidemiology and Global Health
- Genetics and Genomics
Background:
Maternal smoking has been linked to adverse health outcomes in newborns but the extent to which it impacts newborn health has not been quantified through an aggregated cord blood DNA methylation (DNAm) score. Here, we examine the feasibility of using cord blood DNAm scores leveraging large external studies as discovery samples to capture the epigenetic signature of maternal smoking and its influence on newborns in White European and South Asian populations.
Methods:
We first examined the association between individual CpGs and cigarette smoking during pregnancy, and smoking exposure in two White European birth cohorts (n=744). Leveraging established CpGs for maternal smoking, we constructed a cord blood epigenetic score of maternal smoking that was validated in one of the European-origin cohorts (n=347). This score was then tested for association with smoking status, secondary smoking exposure during pregnancy, and health outcomes in offspring measured after birth in an independent White European (n=397) and a South Asian birth cohort (n=504).
Results:
Several previously reported genes for maternal smoking were supported, with the strongest and most consistent association signal from the GFI1 gene (6 CpGs with p<5 × 10-5). The epigenetic maternal smoking score was strongly associated with smoking status during pregnancy (OR = 1.09 [1.07, 1.10], p=5.5 × 10-33) and more hours of self-reported smoking exposure per week (1.93 [1.27, 2.58], p=7.8 × 10-9) in White Europeans. However, it was not associated with self-reported exposure (p>0.05) among South Asians, likely due to a lack of smoking in this group. The same score was consistently associated with a smaller birth size (–0.37±0.12 cm, p=0.0023) in the South Asian cohort and a lower birth weight (–0.043±0.013 kg, p=0.0011) in the combined cohorts.
Conclusions:
This cord blood epigenetic score can help identify babies exposed to maternal smoking and assess its long-term impact on growth. Notably, these results indicate a consistent association between the DNAm signature of maternal smoking and a small body size and low birth weight in newborns, in both White European mothers who exhibited some amount of smoking and in South Asian mothers who themselves were not active smokers.
Funding:
This study was funded by the Canadian Institutes of Health Research Metabolomics Team Grant: MWG-146332.
-
- Cancer Biology
- Genetics and Genomics
It takes more than 20 years for normal colorectal mucosa to develop into metastatic carcinoma. The long time window provides a golden opportunity for early detection to terminate the malignant progression. Here, we aim to enable liquid biopsy of T1a stage colorectal cancer (CRC) and precancerous advanced adenoma (AA) by profiling circulating small extracellular vesicle (sEV)-derived RNAs. We exhibited a full RNA landscape for the circulating sEVs isolated from 60 participants. A total of 58,333 annotated RNAs were detected from plasma sEVs, among which 1,615 and 888 sEV-RNAs were found differentially expressed in plasma from T1a stage CRC and AA compared to normal controls (NC). Then we further categorized these sEV-RNAs into six modules by a weighted gene coexpression network analysis and constructed a 60-gene t-SNE model consisting of the top 10 RNAs of each module that could well distinguish T1a stage CRC/AA from NC samples. Some sEV-RNAs were also identified as indicators of specific endoscopic and morphological features of different colorectal lesions. The top-ranked biomarkers were further verified by RT-qPCR, proving that these candidate sEV-RNAs successfully identified T1a stage CRC/AA from NC in another cohort of 124 participants. Finally, we adopted different algorithms to improve the performance of RT-qPCR-based models and successfully constructed an optimized classifier with 79.3% specificity and 99.0% sensitivity. In conclusion, circulating sEVs of T1a stage CRC and AA patients have distinct RNA profiles, which successfully enable the detection of both T1a stage CRC and AA via liquid biopsy.